Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels

Authors

• Jose de Leon, Mental Health Research Center, Eastern State Hospital, Lexington, KY, USA.
• Georgios Schoretsanitis, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zürich, Zürich, Switzerland.
• Robert L. Smith, Center for Psychopharmacology, Diakonhjemmet Hospital, Oslo, Norway.
• Espen Molden, Center for Psychopharmacology, Diakonhjemmet Hospital, Oslo, Norway.
• Anssi Solismaa, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
• Niko Seppälä, Department of Psychiatry, Satasairaala, Finland.
• Miloslav Kopeček, National Institute of Mental Health, Klecany, Czech Republic.
• Patrik Švancer, National Institute of Mental Health, Klecany, Czech Republic.
• Ismael Olmos, Clinical Pharmacology Unit and Pharmacy Department, Vilardebó Hospital, Administración de Servicios de Salud, Montevideo, Uruguay.
• Carina Ricciardi, Clinical Pharmacology Unit and Outpatient Clinic, Vilardebó Hospital, Administración de Servicios de Salud, Montevideo, Uruguay.
• Celso Iglesias-Garcia, Universidad de Oviedo. CIBERSAM. INEUROPA. ISPA-FIMBA, Oviedo, Spain.
• Ana Iglesias-Alonso, Hospital Universitario Central de Asturias, Oviedo, Spain.
• Edoardo Spina, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
• Can-Jun Ruan, Laboratory of Clinical Psychopharmacology, Beijing Anding Hospital, Capital Medical University, Beijing, China.
• Chuan-Yue Wang, The National Clinical Research Centre for Mental Disorders & Beijing Key Lab of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China.
• Gang Wang, The National Clinical Research Centre for Mental Disorders & Beijing Key Lab of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China.
• Yi-Lang Tang, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia, USA.
• Shih-Ku Lin, Department of Psychiatry, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
• Hsien-Yuan Lane, Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
• Yong Sik Kim, Department of Neuropsychiatry, Nowon Eulji Medical Center, Eulji University, School of Medicine, Seoul, Korea.Follow
• Se Hyun Kim, Department of Psychiatry, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.Follow
• Anto P. Rajkumar, Department of Psychiatry, Christian Medical College, Vellore, India.
• Dinora F. González-Esquivel, Instituto Nacional de Neurología y Neurocirugía, México City, México.
• Helgi Jung-Cook, Instituto Nacional de Neurología y Neurocirugía, México City, México.
• Trino Baptista, Department of Physiology, Los Andes University Medical School, Mérida, Venezuela.
• Christopher Rohde, Department of Affective Disorders, Aarhus University Hospital - Psychiatry, Aarhus, Denmark.
• Jimmi Nielsen, Mental Health Centre Glostrup, Copenhagen University Hospital, Copenhagen, Denmark.
• Hélène Verdoux, Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, Team Pharmacoepidemiology, UMR 1219, F-33000 Bordeaux, France.
• Clelia Quiles, Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, Team Pharmacoepidemiology, UMR 1219, F-33000 Bordeaux, France.
• Emilio J. Sanz, Department of Physical Medicine and Pharmacology, School of Medicine, Universidad de La Laguna, Canary Islands, Spain.
• Carlos De Las Cuevas, Department of Internal Medicine, Dermatology and Psychiatry, School of Medicine, and Instituto Universitario de Neurociencia (IUNE), University of La Laguna, Canary Islands, Spain.
• Dan Cohen

Author Type(s)

Faculty

DOI

10.1055/a-1737-1527

Journal Title

Pharmacopsychiatry

First Page

e1

Document Type

Article

Publication Date

3-1-2022

Department

Psychiatry and Behavioral Sciences

Disciplines

Medicine and Health Sciences

Recommended Citation

de Leon, J., Schoretsanitis, G., Smith, R. L., Molden, E., Solismaa, A., Seppälä, N., Kopeček, M., Švancer, P., Olmos, I., Ricciardi, C., Iglesias-Garcia, C., Iglesias-Alonso, A., Spina, E., Ruan, C., Wang, C., Wang, G., Tang, Y., Lin, S., Lane, H., Kim, Y. S., Kim, S. H., Rajkumar, A. P., González-Esquivel, D. F., Jung-Cook, H., Baptista, T., Rohde, C., Nielsen, J., Verdoux, H., Quiles, C., Sanz, E. J., De Las Cuevas, C., & Cohen, D. (2022). Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels. Pharmacopsychiatry, 55 (2), e1. https://doi.org/10.1055/a-1737-1527